Zelminemab, CAS 2225850-33-7

Product Description: Zelminemab (AMG-301) is a humanized monoclonal antibody that inhibits PACAP type I (PAC1) receptor[1].

Applications: Neuroscience-Neuromodulation

Formula: N/A

References: [1]Eloisa Rubio-Beltrán, et al. PACAP38 and PAC1 receptor blockade: a new target for headache? J Headache Pain. 2018 Aug 7;19(1):64. /[2]Hoffmann J, et al. PAC-1 receptor antibody modulates nociceptive trigeminal activity in rat. Cephalalgia. 2016;36(1S):141–141.

CAS Number: 2225850-33-7

Molecular Weight: N/A

Compound Purity: 98.79

Research Area: Neurological Disease

Solubility: 10 mM in DMSO

Target: Adenylate Cyclase

• SKU: MEXHY-P99509-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99509-5
• Package Unit: 5 mg
• Quantity Unit: STK
• Conjugate: Unconjugated